Blog

House Rule 5687 Referred to Senate

Jul12
By: Stericycle

On June 19, 2018, House Rule 5687, the “SOUND Disposal and Packaging Act,” was passed by the House of Representatives and referred to the Senate.

H.R.5687 directs the Food and Drug Administration (FDA) to work with manufacturers to establish programs for efficient return or destruction of unused Schedule II or III opioids. These methods could include mailback pouches, such as the mailback envelopes provided by Stericycle Environmental Solutions, to secure facilities for incineration, or methods to inactivate immediately or render unattractive unused drugs.

Additionally, the bill will facilitate utilization of packaging that may reduce overprescribing, diversion or abuse of opioids. It will also require the Government Accountability Office (GAO) to study new and innovative technologies that claim to be able to dispose of opioids safely and other unused medications. GAO would review and detail the effectiveness of these disposal methods.

In further effort to combat the nationwide opioid crisis, H.R.5628, the “Access to Increased Drug Disposal Act of 2018,” continues to gain sponsorship. The bill provides for the Drug Enforcement Agency (DEA) to make grants to states to help with the cost of acquiring and disposing of controlled substances as a way of combatting the growing opioid crisis in America.

Stericycle Environmental Solutions is committed to fighting the opioid crisis through its medication collection kiosks and mailback envelopes. Providing a simple and convenient way for consumers to dispose of unused and expired drugs, these kiosks and envelopes are ideal for removing opioids from medicine cabinets across the U.S. in a safe and environmentally-friendly way.

To learn more about theses award-winning medication collection kiosks and envelopes from Stericycle Environmental Solutions, click here.